Schedule 13G ownership disclosure

ZYNERBA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 98986X109

Event date: 2021-05-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,613,332
Percent of class
11.1800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-21-030211
Form type
SC 13G/A
Filer
ETF MANAGERS GROUP, LLC
CIK
CIK 1645173
Filed
Jun 01, 2021
Reporting period
May 28, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub